Eliapharma Services inc.

Location

You can select more than more location by keeping ctrl key pressed and clicking on locations

Eliapharma Services inc.

Eliapharma Services inc. is a Contract Research Organization located in Laval, Quebec. Eliapharma Services inc. provides Specialized Analytical Services for Biotechs, Research Centers, Pharmaceutical Companies and Hospitals

Phone:

(450) 686-5800
Fax:

(450) 686-5811
Email:

info@eliapharma.com
Website:

http://www.eliapharma.com
Address:

230 Bernard Belleau, Suite 166 Laval, QC, , H7V

North America
Canada

Service Information

ANALYTICAL

API Type

Biological Peptide and Protein Small Molecule

Sample Type

API

Service Type

Methods Method Development Method Transfer Method Validation Tests - Impurities/Degradation Imp./Deg Quantitation Tests - Stability Stability Storage (I/II)Stability Testing (I/II)Tests/Analysis - Other Assay/Potency

API/BIOLOGICS/REAGENTS

API Development Stage

GMP clinical Preclinical

API Services

Medicinal Chemistry

API Types

Radiolabeled

BIO-ANALYTICAL

Services

Assays and Supplies Molecular Biology General Methods Development and Validation GMP-GLP Bioanalytical GLP Pre-GLP Metabolite Identification

DISCOVERY/PRECLINICAL

Discovery Services

High throughput screening

PHARMACOKINETICS

Animal List ADME

Mice Primates Rats

Service Types ADME

ADME- In vitro ADME/PK-In vivo In Vitro Metabolism

PREFORMULATION

Preformulation Services

Solubility

TOXICOLOGY

Animals Housed

Dogs Guinea pigs Hamster Mice Primates Rabbit Rats Swine

Toxicology Services

Acute Tox Histology In vivo Tox Pathology Repeat Dose/Sub-Acute Safety Pharmacology Toxicokinetics

World
Ex_US
Japan
Europe
USA
Asia
Africa
Middle East
North America
Central America
South America
Latin America
Ex_Asia
Ex_Europe
Eastern Europe
Northern Europe
Ex_Japan
Argentina
Australia
Austria
Bahamas
Bahrain
Belgium
Brazil
Canada
China
Cyprus
Czech Republic
Denmark
Ecuador
Far East
Finland
France
Germany
Greece
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Jordan
Luxembourg
Mexico
Monaco
Netherlands
New Zealand
Norway
Portugal
Puerto Rico
Repubblica di San Marino
Russia
Singapore
Slovenia
South Africa
South Korea
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
Bermuda
Bosnia and Herzegovina
Croatia
Cuba
Egypt
Estonia
Liechtenstein
Malta
Malaysia
Mauritius
Pakistan
Poland
Romania
Thailand
United Arab Emirates
Vietnam
Ukraine
Georgia
Peru
Lithuania
Serbia
Oman
Armenia
Iran
Kuwait
Lebanon
Qatar
Saudi Arabia
Uzbekistan
Chile
Philippines
Algeria
Syria
Iraq
Latvia
Slovak Republic
Bulgaria
Morocco
Bangladesh
Scandinavia
Hong Kong
Western Europe
Baltic States
Mozambique
Colombia
Uganda
Dominican Republic
Kenya
Costa Rica
Panama
Tunisia
Tanzania
Guinea-Bissau
Moldova
Macedonia, The Former Yugoslav Republic of
Afghanistan
Albania
Gambia
Ghana
Belarus
Nepal
Mali
Haiti
Trinidad and Tobago
Seychelles
Guatemala
Kazakhstan
Venezuela
Cameroon
Senegal
Madagascar
Yemen
Uruguay
Sri Lanka
Gabon
Botswana
Zambia
Burkina Faso
Former Serbia and Montenegro
Fiji
Malawi
Zimbabwe
Nauru
Nicaragua
Solomon Islands
Libyan Arab Jamahiriya
Ethiopia
Martinique
Jamaica
Congo
Benin
Bolivia
El Salvador
Northern Mariana Islands
Cambodia
Nigeria
American Samoa
Former Yugoslavia
Niger
Montenegro
Azerbaijan
Sudan
Rwanda
Virgin Islands (U.S.)
Honduras
Barbados
Reunion
Guinea
Saint Kitts and Nevis
Papua New Guinea
The Democratic Republic of the Congo
Mauritania
Netherlands Antilles
Paraguay
Andorra
Guadeloupe
Mongolia
Central African Republic
Burundi
Brunei Darussalam
Myanmar
Lao People's Democratic Republic
Liberia
Belize
Togo
Sierra Leone
New Caledonia
Grenada
Kyrgyzstan
Angola
Swaziland
Côte D'Ivoire
Chad
Equatorial Guinea
Southern Europe
Australasia
Lesotho
Macau
Congo, The Democratic Republic of the
French Polynesia
Oceania